Table 4.

Patient clinical and demographic characteristics in patient affected by HCV

HCV infection	1	2	3	4	5	6°
Gender	M	F	M	F	F	M°
Age [years]	53	61	58	66	53	57°
HCV Ab	Positive	Positive	Positive	Positive	Positive	Positive°
HCV RNA	Positive	Negative	Negative	Negative	Negative	Negative°
GOT	85	55	43	86	55	59°
GPT	72	52	51	82	48	40°
γ-GT-	78	72	68	71	36	77°
Total bilirubin					2	1.1°
Alkaline phosphatase	–	–	–	–	309	–°
Fibroscan	Second grade Fibrosis (F2)	–	–	–	–	–°
HCV follow-up	No worsening	No worsening	No worsening	No worsening	No worsening	No worsening°
Duration of adalimumab therapy [weeks]	72	72	72	72	96	24°
PASI response	PASI 100	PASI 100	PASI 100	PASI 100	PASI 100	PASI 75°

^°Co-infection HIV/HCV.